Every rating change, initiation and price-target move the sell side published across the equities tracked here, newest first.
Ratings are attributed to the research firm, not to individual analysts. Latest event 15h ago.
Showing the 27 most recent target moves over 7 days.
| Neutral |
| $65 $59 |
| 6d ago |
| VSCOVictorias Secret & Co. | UBS | Maintained | Neutral | $95 $87 | 5d ago |
| CVSCVS Health Corporation | UBS | Maintained | Buy | $126 $118 | 6d ago |
| NOCNorthrop Grumman Corporation | UBS | Maintained | Buy | $685 $704 | 1d ago |
| GDGeneral Dynamics Corporation | UBS | Maintained | Neutral | $395 $408 | 1d ago |
| DGXQuest Diagnostics Incorporated | UBS | Maintained | Neutral | $232 $245 | 1d ago |
| NTAPNetApp, Inc. | UBS | Maintained | Neutral | $160 $171 | 6d ago |
| MDTMedtronic plc | UBS | Maintained | Buy | $100 $110 | 6d ago |
| BF-BBrown-Forman Corporation | UBS | Maintained | Neutral | $27 $30 | 5d ago |
| TEVATeva Pharmaceutical Industries Limited | UBS | Maintained | Buy | $42 $48 | 5d ago |
| ETNEaton Corporation plc | UBS | Upgraded from Neutral | Buy | $450 $515 | 1d ago |
| LMTLockheed Martin Corporation | UBS | Upgraded from Neutral | Buy | $581 $674 | 1d ago |
| SNOWSnowflake Inc. | UBS | Maintained | Buy | $425 $500 | 6d ago |
| ECHOEchoStar Corporation | UBS | Upgraded from Neutral | Buy | $127 $150 | 1d ago |
| WSTWest Pharmaceutical Services, Inc. | UBS | Maintained | Buy | $340 $415 | 18h ago |
| VCYTVeracyte, Inc. | UBS | Maintained | Buy | $52 $65 | 18h ago |
| ASANAsana, Inc. | UBS | Maintained | Neutral | $8 $10 | 5d ago |
| VLOValero Energy Corporation | UBS | Maintained | Buy | $355 $450 | 1d ago |
| PSXPhillips 66 | UBS | Maintained | Buy | $235 $300 | 1d ago |
| DOCUDocuSign, Inc. | UBS | Maintained | Neutral | $54 $70 | 5d ago |
| WATWaters Corporation | UBS | Upgraded from Neutral | Buy | $375 $490 | 23h ago |
| MPCMarathon Petroleum Corporation | UBS | Maintained | Buy | $321 $450 | 1d ago |
| AVTRAvantor, Inc. | UBS | Maintained | Neutral | $10.5 $16 | 20h ago |
| ILMNIllumina, Inc. | UBS | Upgraded from Neutral | Buy | $135 $260 | 23h ago |
| TXG10x Genomics, Inc. | UBS | Maintained | Neutral | $20 $68 | 18h ago |